137 related articles for article (PubMed ID: 21681282)
1. [Clinical characteristics and follow-up management of 135 children with myasthenia gravis].
Yang ZX; Xiong H; Zhang YH; Bao XH; Jiang YW; Wu Y; Wang S; Chang XZ; Qin J; Lin Q; Wu XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):455-9. PubMed ID: 21681282
[TBL] [Abstract][Full Text] [Related]
2. [Myasthenia gravis in children: clinical study of 77 patients].
Zhou SZ; Li WH; Sun DK
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):256-9. PubMed ID: 15157383
[TBL] [Abstract][Full Text] [Related]
3. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis.
Li M; Han J; Zhang Y; Lv J; Zhang J; Zhao X; Ren L; Fang H; Yang J; Zhang Y; Cui X; Zhang Q; Li Q; Du Y; Gao F
Eur J Neurol; 2019 Oct; 26(10):1296-e84. PubMed ID: 31050101
[TBL] [Abstract][Full Text] [Related]
7. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
8. Clinical and serological study of myasthenia gravis in HuBei Province, China.
Zhang X; Yang M; Xu J; Zhang M; Lang B; Wang W; Vincent A
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):386-90. PubMed ID: 17088330
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and electrophysiological peculiarities of seronegative myasthenia].
Shcherbakova NI; Sanadze AG; Sidnev DV; Rudnichenko VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):4-10. PubMed ID: 18427534
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis in children: analysis of 18 patients.
Morita MP; Gabbai AA; Oliveira AS; Penn AS
Arq Neuropsiquiatr; 2001 Sep; 59(3-B):681-5. PubMed ID: 11593264
[TBL] [Abstract][Full Text] [Related]
12. An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis.
Motobayashi M; Inaba Y; Nishimura T; Kobayashi N; Nakazawa Y; Koike K
Pediatr Neurol; 2015 Apr; 52(4):404-9. PubMed ID: 25661289
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
14. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis: a study from India.
Singhal BS; Bhatia NS; Umesh T; Menon S
Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.
Wong V; Hawkins BR; Yu YL
Acta Neurol Scand; 1992 Jul; 86(1):68-72. PubMed ID: 1519477
[TBL] [Abstract][Full Text] [Related]
17. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years.
Huang X; Liu WB; Men LN; Feng HY; Li Y; Luo CM; Qiu L
Neurol Sci; 2013 Jun; 34(6):911-7. PubMed ID: 22806326
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
20. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome.
Afifi AK; Bell WE
J Child Neurol; 1993 Oct; 8(4):403-11. PubMed ID: 8228040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
